168 related articles for article (PubMed ID: 27587361)
21. Serological biomarkers for management of primary sclerosing cholangitis.
Tornai D; Ven PL; Lakatos PL; Papp M
World J Gastroenterol; 2022 Jun; 28(21):2291-2301. PubMed ID: 35800183
[TBL] [Abstract][Full Text] [Related]
22. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Bergquist A; Broomé U
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
[TBL] [Abstract][Full Text] [Related]
23. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
de Groen PC
Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
[No Abstract] [Full Text] [Related]
24. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.
Berr F; Wiedmann M; Mössner J; Tannapfel A; Schmidt F
Hepatology; 1999 Feb; 29(2):611-3. PubMed ID: 10026030
[No Abstract] [Full Text] [Related]
25. Impact of Crohn's Disease Duration on the Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
Cui DJ; Zhao X; Hu M
Am J Gastroenterol; 2017 Jan; 112(1):185. PubMed ID: 28050039
[No Abstract] [Full Text] [Related]
26. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
Lazaridis KN
Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
[No Abstract] [Full Text] [Related]
27. [Clinicopathological features of non-specific cholangitis mimicking cholangiocarcinoma].
Takayashiki T; Furukawa K; Ohtsuka M
Nihon Shokakibyo Gakkai Zasshi; 2020; 117(8):689-694. PubMed ID: 32779586
[No Abstract] [Full Text] [Related]
28. [A case of segmental primary sclerosing cholangitis associated with early cholangiocarcinoma--a review of the Japanese literature].
Kaieda M; Hamada N; Ishizaki N; Nakamura N; Kadono J; Fukueda M; Sakata R; Higashi M; Kitajima S; Yonezawa A
Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):307-12. PubMed ID: 11925870
[No Abstract] [Full Text] [Related]
29. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA 19-9.
Rogers SA; Podolsky DK
Hepatology; 1994 Feb; 19(2):543-5. PubMed ID: 8294114
[No Abstract] [Full Text] [Related]
30. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
31. Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease.
Deneau M; Adler DG; Schwartz JJ; Hutson W; Sorensen J; Book L; Lowichik A; Guthery S
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):617-20. PubMed ID: 21502832
[No Abstract] [Full Text] [Related]
32. Cholangiocarcinoma Resembling IgG4-related Sclerosing Cholangitis.
Akahoshi K; Kanno A; Miwata T; Nagai H; Yokoyama K; Ikeda E; Ando K; Tamada K; Fukushima N; Lefor AK; Yamamoto H
Intern Med; 2023 Dec; 62(23):3495-3500. PubMed ID: 37081688
[TBL] [Abstract][Full Text] [Related]
33. IgG4-Related Sclerosing Cholangitis: A Clinical and Imaging Review.
Madhusudhan KS; Das P; Gunjan D; Srivastava DN; Garg PK
AJR Am J Roentgenol; 2019 Dec; 213(6):1221-1231. PubMed ID: 31509439
[No Abstract] [Full Text] [Related]
34. Unprecedented extrahepatic bile duct images of multiple submucosal tumor-like protrusions in the nonstricture area of patients with immunoglobulin G4-related sclerosing cholangitis.
Ishii Y; Serikawa M; Oka S
Dig Endosc; 2023 May; 35(4):e67-e69. PubMed ID: 36915275
[No Abstract] [Full Text] [Related]
35. [Sclerosing cholangitis with autoimmune pancreatitis which resembles cholangiocarcinoma].
Kodama M; Murakami K; Okimoto T; Takayama A; Shiota S; Yasaka S; Otsu S; Ono M; Yoshiiwa A; Fujioka T
Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2525-8. PubMed ID: 18069307
[No Abstract] [Full Text] [Related]
36. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
Siqueira E; Schoen RE; Silverman W; Martin J; Rabinovitz M; Weissfeld JL; Abu-Elmaagd K; Madariaga JR; Slivka A
Gastrointest Endosc; 2002 Jul; 56(1):40-7. PubMed ID: 12085033
[TBL] [Abstract][Full Text] [Related]
37. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma.
Chung DT; Tang CN; Lai EC; Yang GP; Li MK
Hong Kong Med J; 2010 Apr; 16(2):149-52. PubMed ID: 20354252
[TBL] [Abstract][Full Text] [Related]
39. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
[TBL] [Abstract][Full Text] [Related]
40. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moff SL; Clark DP; Maitra A; Pandey A; Thuluvath PJ
J Clin Gastroenterol; 2006 Apr; 40(4):336-41. PubMed ID: 16633106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
